Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q2 EPS of ($0.27), $0.01 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $7.3 million versus the consensus estimate of $7.75 million.

GUIDANCE:

Rapid Micro Biosystems, Inc. sees FY2025 revenue of ~$32 million, versus the consensus of $32.43 million.

For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.